Filter Results :

Your search for Immune returned 151 reports

Sort by

Global Autoimmune Partnering 2010-2016: Deal trends, players and financials

01 Oct 2016  |  Published by:  CurrentPartnering
Global Autoimmune Partnering 2010 to 2016 provides the full collection of Autoimmune disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010. -Trends in Autoimmune partnering deals -Financial deal terms for headline, upfront and royalty by stage of deve...

$ 2,995.00

Read More

Global Autoimmune Disease Diagnostics Market 2017-2021

30 Sep 2016  |  Published by:  Technavio-Infiniti Research
About the Autoimmune Disease Diagnostics Market Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune...

$ 3,500.00

Read More

MedImmune, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

24 Aug 2016  |  Published by:  GlobalData
SummaryMedImmune, LLC (MedImmune), is a biotechnology company operating as the global biologics subsidiary of AstraZeneca. It focuses on the research, development, manufacture and marketing of biologics to address some of the major medical needs. The company develops therapeutic proteins, monoclonal...

$ 250.00

Read More

Global Plasma-derived Immune Inhibitors Sales Market Report 2021

16 Aug 2016  |  Published by:  QYResearch
This report studies sales (consumption) of Plasma-derived Immune Inhibitors in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these reg...

$ 4,000.00

Read More

Immune Pharmaceuticals Inc. - Product Pipeline Review - 2016

27 Jul 2016  |  Published by:  Global Markets Direct
Summary‘Immune Pharmaceuticals Inc. - Product Pipeline Review, 2016’, provides an overview of the Immune Pharmaceuticals Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Immune Pharmaceuticals Inc., complete ...

$ 1,500.00

Read More

U.S. Therapeutic Plasma Exchange Market by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Guillain Barre Syndrome, Multiple Sclerosis, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - Forecasts to 2021

19 Jul 2016  |  Published by:  MarketsandMarkets
The U.S. therapeutic plasma exchange (TPE) market by indication is estimated to reach USD 260.0 million by 2021, growing at a CAGR of 11% to 12% during the forecast period (2016 to 2021). The rising incidences of blood disorders and chronic diseases; rapid increase in the aging population; and...

$ 5,650.00

Read More

Immune Check Activators- Competitive Landscape, Technology and Pipeline Analysis, 2016

04 Jul 2016  |  Published by:  DelveInsight
DelveInsight's report deals with the TNFR/TNF superfamily members as agents of Cancer Immunotherapy that have brought a new dawn upon the existing therapies for cancer. Controlling diverse facets of immune function, it has brought into application a technology that res...

$ 1,750.00

Read More

Global Autoimmune Disorders Market Research Report 2016

21 Jun 2016  |  Published by:  9Dimen Research
2016 Global Autoimmune Disorders Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Autoimmune Disorders industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan an...

$ 2,850.00

Read More

Immune Checkpoint Therapeutics - Hot Targets & Pipeline Analysis

26 Apr 2016  |  Published by:  IQ4I Research and Consultancy
“IMMUNE CHECKPOINT THERAPEUTICS – HOT TARGETS & PIPELINE ANALYSIS” gives comprehensive insights on the various Immune Checkpoint modulators being developed for the treatment of various diseases. The report covers all the drugs being developed in various phases (Discovery, Preclinical &...

$ 4,500.00
$ 4,050.00
( Save 10% )

Read More

TapImmune Inc. (TPIV) - Financial and Strategic SWOT Analysis Review

15 Apr 2016  |  Published by:  GlobalData
SummaryTapImmune Inc. (TapImmune) is a biotechnology company that develops peptide and gene based immunotherapeutics and vaccines for treatment of oncology and infectious disease. It conducts preclinical immunotherapeutic programs for clinical trials. TapImmune's immunotherapy technologies are used ...

$ 300.00

Read More

Adimmune Corporation (4142) - Financial and Strategic SWOT Analysis Review

15 Apr 2016  |  Published by:  GlobalData
SummaryAdimmune Corporation (Adimmune) is a pharmaceutical company that offers vaccines. The company manufactures vaccines, diagnostics, and biological products. Its products include Japan encephalitis vaccine, tetanus toxoid adsorbed vaccine, influenza vaccine, and ah1n1 vaccine. Adimmune provides ...

$ 300.00

Read More

MedImmune, LLC - Product Pipeline Review - 2016

13 Apr 2016  |  Published by:  Global Markets Direct
Summary‘MedImmune, LLC - Product Pipeline Review - 2016’, provides an overview of the MedImmune, LLC’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by MedImmune, LLC, complete with analysis by stage of development,...

$ 1,500.00

Read More

MedImmune, LLC - Strategic SWOT Analysis Review

05 Apr 2016  |  Published by:  GlobalData
MedImmune, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and service...

$ 125.00

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2016

22 Mar 2016  |  Published by:  Global Markets Direct
Summary‘Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2016’, provides an overview of the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) pipeline landscape. The report provides comprehensive information on the therap...

$ 2,000.00

Read More

Global Autoimmune Drugs Market 2016-2020

18 Mar 2016  |  Published by:  Technavio-Infiniti Research
About Autoimmune Diseases Drugs Autoimmune diseases are immunological disorders that occur when the immune system attacks and destroys healthy tissues in the body rather than foreign bodies, causing significant pain, inflammation, and organ damage. These diseases can affect the nervous syst...

$ 2,500.00

Read More
Total 151 records.